Evidence map›Paper›PMID 41422037›Full record

ArticleCell death & disease2025

Downregulation of Engulfment and cell motility 1 (Elmo1) induces quiescence and resistance to poly(I:C)-induced apoptosis in endothelial cells.

Yukako Kayashima, Anshulika A Deshmukh, Yuki Kiyokawa, Niroshani M W Wariyapperuma Appuhamillage, Jiayi Zhou, Mohamed-Yahia S Monawar, Melanie Nassar-Guifarro, Feng Li, Nobuyo Maeda

Abstract read
In one paragraph

Article in Cell death & disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yukako KayashimaDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. yukaya@email.unc.edu.ORCID http://orcid.org/0000-0003-3415-9135
Anshulika A DeshmukhDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Yuki KiyokawaDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Niroshani M W Wariyapperuma AppuhamillageDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Jiayi ZhouDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID http://orcid.org/0009-0009-7301-2698
Mohamed-Yahia S MonawarDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Melanie Nassar-GuifarroDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Feng LiDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nobuyo MaedaDepartment of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Hazel B Nichols · 2001 to 2026
$36.3M
MODELS FOR STUDYING THE GENETICS OF HYPERTENSIONR01HL049277 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MAEDA, NOBUYO · 1992 to 2025
$17.5M
Benefits of nicotinamide in placental development and in preeclamsiaR01HD101485 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LI, FENG · 2021 to 2025
$2.1M
NCI NIH HHS P30 CA016086NHLBI NIH HHS R01 HL049277NICHD NIH HHS R01 HD101485NIEHS NIH HHS P30 ES010126U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD101485U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL049277
6 · The paper itself

Abstract

Severe viral infections can cause cell death as a protective mechanism to eliminate defective cells and limit further viral propagation. However, the precise mechanism underlying the decision between cell survival and death remains unclear. Here, we demonstrate that Engulfment and Cell Motility 1 (ELMO1), an intracellular protein that facilitates cytoskeleton rearrangement through activation of Rac family small GTPase 1 (RAC1), is involved in the Toll-like receptor 3 (TLR3)-induced apoptosis in human umbilical vein endothelial cells. RNA sequencing of cells treated with ELMO1-targeting siRNA (siELMO1) revealed that knockdown of ELMO1 increased the transcripts of extracellular matrix genes including COL5A1 and decreased the expression of cell cycle and DNA replication-related genes such as CCND1 and CDK1. These siELMO1 treated cells also showed G1/S cell cycle arrest. When stimulated with polyinosinic-polycytidylic acid (poly(I:C)), a TLR3 agonist, inflammatory cytokines and chemokines such as CXCL8 and IL6 robustly increased in Mock-treated cells, while siNT (non-targeting) cells underwent massive cell death and showed reduced inflammatory responses, reflecting apoptosis-inducing effects of sequential TLR3 activation by siRNA and poly(I:C). Strikingly, siELMO1 cells were resistant to the cell death, and restored inflammatory cytokine responses to the same level as Mock-treated cells. Mechanistically, apoptosis in siNT increased through the activation of caspase-8, whereas downregulation of ELMO1 inhibited the cleavage of caspase-8. These results indicate that ELMO1 is involved in the regulation between survival or death in endothelial cells through the regulation of caspase-8 activity downstream of TLR3, suggesting the importance of the ELMO1 in cell proliferation as well as susceptibility to poly(I:C)-induced apoptosis.

Indexed as

Adaptor Proteins, Signal TransducingApoptosisHuman Umbilical Vein Endothelial CellsPoly I-CCaspase 8Down-RegulationHumansRNA, Small InterferingToll-Like Receptor 3Adaptor Proteins, Signal TransducingCaspase 8ELMO1 protein, humanPoly I-CRNA, Small InterferingTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID41422037
PMCPMC12847878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.